Critical Medical Supplies Exhausted Amid Surge in Rare Paralysis Syndrome Cases in Gaza, WHO Reports

Spread the Message

Read Time:4 Minute, 3 Second

The World Health Organization (WHO) has issued a grave warning regarding the depletion of critical medical supplies in Gaza amid a surge in cases of Guillain-Barré syndrome (GBS), a rare and potentially life-threatening neurological disorder. Since June 2025, 94 confirmed cases of GBS have been reported in Gaza, resulting in 10 fatalities, a dramatic increase from previous years where such cases were seldom seen. The escalating health crisis unfolds against a backdrop of severe shortages in essential medical resources, severely constraining treatment options for affected patients.

Key Findings and Developments

Guillain-Barré syndrome is an uncommon condition where the immune system mistakenly attacks peripheral nerves, leading to muscle weakness, paralysis, and in severe cases, respiratory failure. The WHO reports that among the 10 deaths, four were children under 15 and six were young adults averaging 25 years old. Alarmingly, two of these fatalities did not receive any medical intervention due to the unavailability of key treatments.

The primary treatment for GBS involves intravenous immune globulin (IVIG) therapy and plasmapheresis, both of which are currently out of stock in Gaza, according to the WHO. The Gaza Ministry of Health identifies IVIG as the first-line treatment for GBS, but the ongoing aid blockade and disruptions in medical supply chains have left healthcare providers without alternatives for patients suspected of having this syndrome.

Dr. Lina Hariri, a neurologist not involved in the WHO report, commented, “The shortage of IVIG and necessary plasmapheresis equipment in Gaza is deeply concerning. GBS, although rare, requires timely intervention to prevent respiratory failure and permanent disability. Lack of treatment will likely increase mortality and morbidity in this vulnerable population.”

Context and Background

The WHO highlights that cases of GBS were rarely reported in Gaza before the Israel-Hamas conflict escalated nearly two years ago. The surge in GBS cases is thought to be driven by worsened gastrointestinal and respiratory infections linked to deteriorated water, sanitation, and hygiene conditions within the enclave. Overcrowding, compromised immunity due to malnutrition, and the overall humanitarian crisis further compound the health challenges facing the population.

Gaza’s healthcare system has been severely strained by repeated conflicts, blockade-induced shortages, damage to infrastructure, and insufficient medical personnel. According to WHO data, more than half a million people in Gaza are currently trapped in famine-like conditions, worsening malnutrition and infectious diseases. Hospitals are operating at minimal capacity, with many facilities damaged or overwhelmed by mass casualties and chronic health needs.

Implications for Public Health

The inability to treat GBS effectively poses a dire public health risk. GBS can progress quickly and requires urgent, specialized care often involving respiratory support. The depletion of IVIG and plasmapheresis supplies means that many patients may suffer prolonged paralysis, long-term disability, or death.

Furthermore, the surge of GBS cases could indicate broader systemic issues, such as heightened infectious disease transmission in Gaza due to compromised sanitary conditions and weakened immunity. Public health experts worry that without immediate restoration of medical supply chains and humanitarian access, fragile health outcomes will worsen.

Potential Limitations and Counterarguments

While the WHO report underscores a rare surge in GBS, Guillain-Barré syndrome is inherently a rare condition with variable incidence globally. Some experts caution that the precise causes of the increase require further epidemiological investigation, including potential new infections or environmental triggers related to conflict conditions.

Moreover, ongoing security concerns and logistical barriers complicate the delivery of accurate data and medical supplies, potentially underestimating the full scope of the crisis.

Balanced Perspective and Expert Commentary

Dr. Tariq al-Mansour, a public health specialist familiar with conflict zones, stated, “This situation vividly illustrates how conflict and humanitarian crises devastate essential health services. Outside interventions to restore medical supply lines and infrastructure, alongside peaceful resolutions, are crucial to prevent further loss of life.”

Medical professionals emphasize that GBS, despite its seriousness, is treatable with timely access to IVIG and plasmapheresis, highlighting the urgency of resolving supply shortages.

Practical Implications for Readers

For health-conscious readers, this crisis signals the critical importance of stable healthcare infrastructure and access to essential treatments during emergencies. It also underscores the interconnected nature of public health, sanitation, nutrition, and conflict. Supporting humanitarian aid efforts and advocating for unimpeded medical access in conflict zones is vital for preventing such avoidable outcomes.

Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.

References: